v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
May 29, 2026
May 30, 2025
Cash flows from operating activities    
Net income $ 90,779 $ 18,285
Adjustments to reconcile net income from continuing operations to net cash provided by operating activities:    
Depreciation expense and amortization of intangible assets 37,877 43,010
Amortization of debt issuance costs 1,892 2,819
Stock-based compensation expense 25,195 33,362
Impairment of goodwill 0 11,373
Loss on impairment of non-marketable equity investment 10,000 0
Gain on disposition of equity investment (30,928) 0
Deferred income taxes, net 321 1,122
Other 526 (2,468)
Changes in operating assets and liabilities:    
Accounts receivable (396,365) (40,760)
Inventories (243,136) (30,776)
Other assets 9,899 13,741
Accounts payable and accrued expenses and other liabilities 505,162 133,908
Net cash provided by operating activities from continuing operations 11,222 183,616
Net cash used for operating activities from discontinued operations 0 (4,099)
Net cash provided by operating activities 11,222 179,517
Cash flows from investing activities    
Capital expenditures and deposits on equipment (7,297) (6,087)
Proceeds from sales and maturities of investment securities 0 27,485
Purchases of held-to-maturity investment securities 0 (46,127)
Proceeds from disposition of equity investments 71,738 0
Other (1,332) (1,015)
Net cash provided by (used for) investing activities from continuing operations 63,109 (25,744)
Net cash provided by investing activities from discontinued operations 0 28,350
Net cash provided by investing activities 63,109 2,606
Cash flows from financing activities    
Proceeds from issuance of preferred shares, net of $8,818 paid issuance costs 0 191,182
Repayments of debt (20,000) 0
Payments to acquire common stock (68,886) (49,240)
Proceeds from restricted cash advances 38,000 0
Payment of preferred stock cash dividends (9,100) (5,100)
Proceeds from issuance of common stock 10,202 7,745
Net cash (used for) provided by financing activities (49,784) 144,587
Net increase in cash, cash equivalents and restricted cash 24,547 326,710
Cash, cash equivalents and restricted cash at beginning of period 454,070 383,477
Cash, cash equivalents and restricted cash at end of period $ 478,617 $ 710,187